Global Burden of Disease Liver Cancer et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the global burden of disease study 2015. JAMA Oncol. 3, 1683–1691. https://doi.org/10.1001/jamaoncol.2017.3055 (2017).
Yang, J. D. et al. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589–604. https://doi.org/10.1038/s41575-019-0186-y (2019).
Dasgupta, P. et al. Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Front. Oncol. 10, 171–171. https://doi.org/10.3389/fonc.2020.00171 (2020).
Wang, M. et al. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Cancer Med. 7, 646–654. https://doi.org/10.1002/cam4.1341 (2018).
Dodson, R. M. et al. Intrahepatic cholangiocarcinoma: Management options and emerging therapies. J. Am. Coll. Surg. 217, 736-750.e734. https://doi.org/10.1016/j.jamcollsurg.2013.05.021 (2013).
Razumilava, N. & Gores, G. J. Cholangiocarcinoma. Lancet 383, 2168–2179. https://doi.org/10.1016/s0140-6736(13)61903-0 (2014).
Wen, N. et al. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci. Trends 16, 20–30. https://doi.org/10.5582/bst.2022.01061 (2022).
Marrero, J. A. & Welling, T. Modern diagnosis and management of hepatocellular carcinoma. Clin. Liver Dis. 13, 233–247. https://doi.org/10.1016/j.cld.2009.02.007 (2009).
Renzulli, M., Golfieri, R., Bologna Liver Oncology Group. Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease. J. Gastroenterol. Hepatol. 31, 69–80. https://doi.org/10.1111/jgh.13150 (2016).
Park, H. J. et al. Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound. J. Hepatol. 72, 718–724. https://doi.org/10.1016/j.jhep.2019.12.001 (2020).
Lee, Y. J. et al. Hepatocellular carcinoma: Diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 275, 97–109. https://doi.org/10.1148/radiol.14140690 (2015).
Colli, A. et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am. J. Gastroenterol. 101, 513–523. https://doi.org/10.1111/j.1572-0241.2006.00467.x (2006).
Pomfret, E. A. et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl. 16, 262–278. https://doi.org/10.1002/lt.21999 (2010).
Yamasaki, S. Intrahepatic cholangiocarcinoma: Macroscopic type and stage classification. J. Hepatobiliary Pancreat. Surg. 10, 288–291. https://doi.org/10.1007/s00534-002-0732-8 (2003).
Lim, J. H. Cholangiocarcinoma: Morphologic classification according to growth pattern and imaging findings. AJR Am. J. Roentgenol. 181, 819–827. https://doi.org/10.2214/ajr.181.3.1810819 (2003).
Xu, J. et al. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int. 32, 1156–1164. https://doi.org/10.1111/j.1478-3231.2012.02783.x (2012).
Sheng, R. F., Zeng, M. S., Rao, S. X., Ji, Y. & Chen, L. L. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (</=3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Clin. Imaging 38, 265–272. https://doi.org/10.1016/j.clinimag.2013.12.022 (2014).
Asayama, Y. et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: Radiologic-pathologic correlation. AJR Am. J. Roentgenol. 190, W28-34. https://doi.org/10.2214/ajr.07.2117 (2008).
Primary Liver Cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann. Surg. 211, 277–287 (1990).
Reau, N. & Poordad, F. Primary Liver Cancer: Surveillance, Diagnosis and Treatment (Springer, 2012).
Joo, I. et al. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI. J. Magn. Reson. Imaging 44, 1330–1338. https://doi.org/10.1002/jmri.25287 (2016).
Chernyak, V. et al. Liver imaging reporting and data system (li-rads) version 2018: Imaging of hepatocellular carcinoma in at-risk patients. Radiology 289, 816–830. https://doi.org/10.1148/radiol.2018181494 (2018).
Cruz, J. A. & Wishart, D. S. Applications of machine learning in cancer prediction and prognosis. Cancer Inform. 2, 59–77 (2006).
Joseph, G. B. et al. Texture analysis of cartilage T2 maps: Individuals with risk factors for OA have higher and more heterogeneous knee cartilage MR T2 compared to normal controls–data from the osteoarthritis initiative. Arthritis Res. Ther. 13, R153. https://doi.org/10.1186/ar3469 (2011).
Skogen, K. et al. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. Eur. J. Radiol. 85, 824–829. https://doi.org/10.1016/j.ejrad.2016.01.013 (2016).
Michoux, N. et al. Texture analysis on MR images helps predicting non-response to NAC in breast cancer. BMC Cancer 15, 574. https://doi.org/10.1186/s12885-015-1563-8 (2015).
Rizzo, S. et al. Radiomics: The facts and the challenges of image analysis. Eur. Radiol. Exp. 2, 36. https://doi.org/10.1186/s41747-018-0068-z (2018).
Olson, R. S., Urbanowicz, R. J., Andrews, P. C., Lavender, N. A. & Moore, J. H. Automating biomedical data science through tree-based pipeline optimization. in European Conference on the Applications of Evolutionary Computation. 9597. https://doi.org/10.1007/978-3-319-31204-0_9 (2016).
Kutlu, H. & Avci, E. A novel method for classifying liver and brain tumors using convolutional neural networks, discrete wavelet transform and long short-term memory networks. Sensors https://doi.org/10.3390/s19091992 (2019).
Ben-Cohen, A. et al. CT Image-based decision support system for categorization of liver metastases into primary cancer sites: Initial results. Acad. Radiol. 24, 1501–1509. https://doi.org/10.1016/j.acra.2017.06.008 (2017).
Yu, H. et al. Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI. J. Magn. Reson. Imaging 42, 1259–1265. https://doi.org/10.1002/jmri.24898 (2015).
Cichos, F., Gustavsson, K., Mehlig, B. & Volpe, G. Machine learning for active matter. Nat. Mach. Intell. 2, 94–103. https://doi.org/10.1038/s42256-020-0146-9 (2020).
Olson, R. S., Bartley, N., Urbanowicz, R. J. & Moore, J. H. Evaluation of a tree-based pipeline optimization tool for automating data science. Proc. Genet. Evol. Comput. Conf. 2016, 485–492. https://doi.org/10.1145/2908812.2908918 (2016).
Waring, J., Lindvall, C. & Umeton, R. Automated machine learning: Review of the state-of-the-art and opportunities for healthcare. Artif. Intell. Med. 104, 101822. https://doi.org/10.1016/j.artmed.2020.101822 (2020).
Le, T. T., Fu, W. & Moore, J. H. Scaling tree-based automated machine learning to biomedical big data with a feature set selector. Bioinformatics 36, 250–256. https://doi.org/10.1093/bioinformatics/btz470 (2020).
Feurer, M. et al. Efficient and robust automated machine learning. Adv. Neural Inf. Process. Syst. 28, 1–10 (2015).
Auto_ml documentation. https://auto-ml.readthedocs.io/en/latest/ (2016).
LeDell, E. & Poirier, S. H2O AutoML: Scalable automatic machine learning. in Proceedings of the AutoML Workshop at ICML (2020).
Swearingen, T. et al. ATM: A distributed, collaborative, scalable system for automated machine learning. in 2017 IEEE International Conference on Big Data (Big Data), 151–162 (2017).
MLBox documentation. https://mlbox.readthedocs.io/en/latest/. (2017)
Orlenko, A. et al. Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure. Pac. Symp. Biocomput. 23, 460–471 (2018).
Sun, H. et al. Identification of suspicious invasive placentation based on clinical MRI data using textural features and automated machine learning. Eur. Radiol. 29, 6152–6162. https://doi.org/10.1007/s00330-019-06372-9 (2019).
Su, X. et al. Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain. Neuro Oncol. https://doi.org/10.1093/neuonc/noz184 (2019).
Haniff, N. S. M. et al. Magnetic resonance imaging radiomics analysis for predicting hepatocellular carcinoma. in 2021 International Congress of Advanced Technology and Engineering (ICOTEN), 1–5 (2021).
Tao, P. et al. 3:”09 PM Abstract No. 299 automatic machine learning based on routine pre procedure magnetic resonance imaging to predict response of hepatocellular carcinoma following transcatheter arterial chemoembolization. J. Vasc. Interv. Radiol. 31, S137. https://doi.org/10.1016/j.jvir.2019.12.352 (2020).
Fedorov, A. et al. 3D Slicer as an image computing platform for the quantitative imaging network. Magn. Reson. Imaging 30, 1323–1341. https://doi.org/10.1016/j.mri.2012.05.001 (2012).
Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159–174 (1977).
Fowler, K. J., Potretzke, T. A., Hope, T. A., Costa, E. A. & Wilson, S. R. LI-RADS M (LR-M): Definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom. Radiol. 43, 149–157. https://doi.org/10.1007/s00261-017-1196-2 (2018).
Zwanenburg, A. et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295, 328–338. https://doi.org/10.1148/radiol.2020191145 (2020).
Radiomics-develop documentation. https://github.com/mvallieres/radiomics-develop. (2019)
Galloway, M. M. Texture analysis using gray level run lengths. Comput. Graphics Image Process. 4, 172–179 (1975).
Thibault, G. et al. Texture indexes and gray level size zone matrix. Application to Cell Nuclei Classification. PRIP, 140–145 (2009).
Haralick, R. M., Shanmugam, K. & Dinstein, I. H. Textural features for image classification. IEEE Trans. Syst. Man Cybern. 1, 610–621 (1973).
Renzulli, M. et al. LI-RADS: A great opportunity not to be missed. Eur. J. Gastroenterol. Hepatol. 31, 283–288. https://doi.org/10.1097/MEG.0000000000001269 (2019).
Min, J. H. et al. EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC. Liver Int. 41, 2986–2996. https://doi.org/10.1111/liv.15012 (2021).
Yasaka, K., Akai, H., Abe, O. & Kiryu, S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: A preliminary study. Radiology 286, 887–896. https://doi.org/10.1148/radiol.2017170706 (2018).
Juntu, J., Sijbers, J., De Backer, S., Rajan, J. & Van Dyck, D. Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft-tissue tumors in T1-MRI images. J. Magn. Reson. Imaging 31, 680–689. https://doi.org/10.1002/jmri.22095 (2010).
Le, T. T., Fu, W. & Moore, J. H. Scaling tree-based automated machine learning to biomedical big data with a feature set selector. Bioinformatics 30, 250–256. https://doi.org/10.1093/bioinformatics/btz470 (2020).
Shortliffe, E. H. & Sepúlveda, M. J. Clinical decision support in the era of artificial intelligence. JAMA 320, 2199–2200. https://doi.org/10.1001/jama.2018.17163 (2018).
Sutton, R. T. et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit. Med. 3, 17. https://doi.org/10.1038/s41746-020-0221-y (2020).
Tovoli, F. et al. Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients. J. Hepatol. 71, 1175–1183. https://doi.org/10.1016/j.jhep.2019.08.015 (2019).
Tovoli, F. et al. Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. Eur. Radiol. 28, 3611–3620. https://doi.org/10.1007/s00330-018-5393-3 (2018).
Wengert, G. J. et al. Differentiation of intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma in the cirrhotic liver using contrast-enhanced MR imaging. Acad. Radiol. 24, 1491–1500. https://doi.org/10.1016/j.acra.2017.06.005 (2017).